Henry Schein (HSIC) : Net money flow in Henry Schein (HSIC) was negative ($1.26 million) and the inflow of money on uptick was $0.9 million, whereas, the outflow of money on downticks amounted to $2.16 million on Monday. The traders used every opportunity of price strength in the stock to sell their positions, hence, the total uptick to downtick ratio was 0.42. The block trades show that the large investors, were aggressive sellers in the stock. On the other hand, the total value of block trades done on downticks was $0 million. The money flow in block trades was negative ($0). Henry Schein (HSIC) gained $0.08 cent during the day and reached $165.54, a gain of 0.05% over the previous day.
Henry Schein, Inc. has lost 0.96% in the last five trading days and dropped 8.95% in the last 4 weeks. Henry Schein, Inc. has dropped 5.58% during the last 3-month period . Year-to-Date the stock performance stands at 3.94%.
Henry Schein (NASDAQ:HSIC): The stock opened at $165.22 on Monday but the bulls could not build on the opening and the stock topped out at $165.81 for the day. The stock traded down to $164.29 during the day, due to lack of any buying support eventually closed down at $164.42 with a loss of -0.63% for the day. The stock had closed at $165.46 on the previous day. The total traded volume was 450,992 shares.
In a related news, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the director officer (EVP, Chief Admin. Officer) of Henry Schein Inc, Benjamin Gerald A had sold 9,991 shares worth of $1,749,124 in a transaction dated June 2, 2016. In this transaction, 9,991 shares were sold at $175.07 per share.
Henry Schein, Inc. provides health care products and services to office-based dental animal health and medical practitioners. The Company operates its business through two segments: health care distribution and technology and value-added services. The health care distribution segment distributes consumable products, laboratory products, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins, among others. The Companys global technology and value-added services segment provides software, technology and other value-added services to health care practitioners. Its offerings include practice management software systems for dental and medical practitioners and animal health clinics. Its value-added practice solutions include financial services on a non-recourse basis, e-services, practice technology, network and hardware services, as well as continuing education services for practitioners.